IMMUNITYBIO
Live / Registered — Registered (as of 24 May 2022)
What this means for you
Registered since 24 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88469975
- Registration number
- 6725241
- Mark type
- Stylized text
- Filed
- 12 Jun 2019
- Published for opposition
- 03 Sept 2019
- Registered
- 24 May 2022
- Attorney of record
- Michael J. McCue
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer; pharmaceutical preparations for immunotherapy treatment; diagnostic kits consisting primarily of cells for medical or clinical use
Owner
- NANTCELL, INC., CULVER CITY, CA, US
- NANTCELL, INC., CULVER CITY, CA, US
- IMMUNITYBIO, INC., CULVER CITY, CA, US
- NantCell, Inc., Culver City, CA, US
- NantCell, Inc., Culver City, CA, US
Prosecution history
- 24 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 07 Apr 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Apr 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Mar 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Feb 2022 — USE AMENDMENT FILED
- 11 Mar 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Feb 2022 — TEAS STATEMENT OF USE RECEIVED
- 03 Nov 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Oct 2021 — SOU EXTENSION 4 GRANTED
- 29 Oct 2021 — SOU EXTENSION 4 FILED
- 29 Oct 2021 — SOU TEAS EXTENSION RECEIVED
- 01 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2021 — SOU EXTENSION 3 GRANTED